Rep. Maria Elvira Salazar (R-FL) Sells UnitedHealth (UNH) Stock

Maria Elvira Salazar, a Republican member of the House from Florida's 27th district, sold shares of UnitedHealth Group Incorporated (NYSE: UNH) on September 24, 2026. The transaction was valued between $1,001 and $15,000, according to a periodic transaction report filed under the STOCK Act on October 7, 2026.

What Changed in Maria Elvira Salazar's UnitedHealth Group Position

Salazar's recent sale adds to the ongoing activity among lawmakers trading shares of UnitedHealth. Her transaction reflects a focus on the healthcare sector, where UnitedHealth operates as a major player.

Other Institutional Activity in UnitedHealth Group

Several notable funds have active positions in UnitedHealth Group. Blackrock Inc. holds 76,863,061 shares, worth about $30.9 billion, having increased its stake by 3,394,259 shares, a 4.6% rise. Vanguard Capital Management LLC has 59,311,525 shares valued at approximately $23.8 billion, adding 441,525 shares, a 0.8% increase. State Street Corporation owns 45,633,267 shares worth about $18.3 billion, with a 0.7% increase from 299,205 shares. Capital World Investors has 29,887,932 shares valued at $12.0 billion, growing its position by 2,103,297 shares, a 7.6% increase. FMR, LLC has a sizeable 27,992,995 shares, valued at $11.2 billion, having increased its holdings by 15,974,192 shares, a significant 132.9% increase.

UnitedHealth Group Incorporated Stock Up 1.5%

As of October 16, 2026, UnitedHealth Group's stock recently traded around $402.7. This price is above its 50-day moving average by 4.0% and its 200-day moving average by 12.3%. However, it is about 12.8% below its 52-week high of $461.62, suggesting it may have room for recovery.

Recent Earnings

UnitedHealth Group reported trailing twelve-month revenue of approximately $450.1 billion. The earnings per share (EPS) for the same period was $15.55. The company is scheduled to report its next earnings on January 26, 2027.

Insider Buying and Selling at UnitedHealth Group Incorporated

Recent insider transactions include Patrick Hugh Conway, an officer at UnitedHealth, who sold 500 shares at an average price of $410.00 on August 5, 2026, totaling about $205,000. He also sold 1,169 shares at an average price of $390.00 on August 21, 2026, valued at approximately $455,910.

Analysts Set New Price Targets

On July 21, 2026, JP Morgan maintained an Overweight rating on UnitedHealth Group with a price target of $516.00. On October 9, 2026, TD Cowen maintained a Hold rating with a target of $402.00, while Piper Sandler and Barclays also maintained their Overweight ratings with targets of $504.00 and $440.00, respectively, on October 14, 2026. Baird maintained a Neutral rating with a target of $427.00 on the same day. The consensus among analysts is a 'buy' recommendation, with a mean price target of $477.04.

About UnitedHealth Group

UnitedHealth Group Incorporated is a healthcare company that provides a wide range of services through its various segments, including health care delivery and management. The company operates both domestically and internationally, serving patients and providers alike. This recent insider sale by Salazar highlights the ongoing interest and activity in the healthcare sector.

Bottom Line

Watch for UnitedHealth's upcoming earnings report on January 26, 2027. Additionally, keep an eye on further trades by lawmakers and any shifts in analyst ratings as the healthcare landscape continues to evolve.